A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.

On Wednesday, Donald Trump pardoned two Washington, D.C., police officers convicted of the 2020 killing of 20-year-old Karon ...

Co., Inc. (NYSE:MRK), a global healthcare leader, faces a complex landscape of opportunities and challenges as it navigates the competitive biopharmaceutical industry. This comprehensive analysis ...

A new initiative, led by the Indian Medical Association (IMA) and the Federation of Obstetric and Gynaecological Societies of ...

An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Anti-RFK Jr. ads target GOP senatorsA ...